Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis
Author:
Funder
Assistance Publique-Hôpitaux de Paris Clinical Research and Development Department
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference16 articles.
1. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis;Otten;JAMA,2011
2. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients;Southwood;Rheumatology,2011
3. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study;Weinblatt;Arthritis Rheum,2008
4. High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study);Navarro-Sarabia;Rheumatology,2011
5. Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis;de Vries;Ann Rheum Dis,2009
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases;Journal of Clinical Medicine;2023-05-04
2. Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study;Pediatric Rheumatology;2023-03-22
3. Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate;2022-09-15
4. Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults;Therapeutic Advances in Musculoskeletal Disease;2021-01
5. SAT0488 ETANERCEPT CONCENTRATION IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS;Annals of the Rheumatic Diseases;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3